Impact BioMedical Inc.
IBO
$0.46
$0.024.39%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 102.06% | 48.59% | 52.09% | -3,893.22% | -806.10% |
| Total Depreciation and Amortization | 197.57% | 495.49% | 24,371.43% | 23,716.67% | 11,400.00% |
| Total Amortization of Deferred Charges | -202.16% | -168.11% | -151.08% | -126.12% | -50.09% |
| Total Other Non-Cash Items | -111.60% | -56.37% | -61.57% | 918.77% | 7,761.73% |
| Change in Net Operating Assets | 392.70% | 213.43% | 198.68% | -200.28% | -174.48% |
| Cash from Operations | 84.89% | 45.25% | 33.78% | -29.29% | -70.62% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.00% | -66.67% | 50.00% | -33.33% | 0.00% |
| Cash from Investing | 50.00% | -66.67% | 50.00% | -33.33% | 100.00% |
| Total Debt Issued | -28.40% | 3.90% | -83.63% | -69.49% | -86.95% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.74% | -91.46% | -102.25% | -93.35% | 102.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.71% | -198.63% | -199.90% | -207.66% | 62,300.00% |